Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection

dc.creatorNeukam, Karin
dc.creatorCaruz, Antonio
dc.creatorRivero Juarez, Antonio
dc.creatorBarreiro, Pablo
dc.creatorMerino, Dolores
dc.creatorReal, Luis M.
dc.creatorHerrero, Rocío
dc.creatorCamacho, Angela
dc.creatorSoriano, Vicente
dc.creatorDi Lello, Federico Alejandro
dc.creatorMacias, Juan
dc.creatorRivero, Antonio
dc.creatorPineda, Juan A.
dc.date.accessioned2015-09-10T16:08:43Z
dc.date.accessioned2018-11-06T11:40:14Z
dc.date.available2015-09-10T16:08:43Z
dc.date.available2018-11-06T11:40:14Z
dc.date.created2015-09-10T16:08:43Z
dc.date.issued2013-11-13
dc.identifierNeukam, Karin; Caruz, Antonio; Rivero Juarez, Antonio; Barreiro, Pablo; Merino, Dolores; et al.; Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection; Lippincott, Williams & Wilkins; AIDS; 27; 17; 13-11-2013; 2715-2724
dc.identifier0269-9370
dc.identifierhttp://hdl.handle.net/11336/2000
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1857300
dc.description.abstractTo identify genetic factors that predict sustained virological response (SVR) to pegylated interferon (Peg-IFN)/ribavirin (RBV) in HIV/hepatitis C virus (HCV) genotype 1 or 4-coinfected patients and that enhance the predictive capacity of IL28B genotype in this population.
dc.languageeng
dc.publisherLippincott, Williams & Wilkins
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/doi:10.1097/01.aids.0000432459.36970.a9
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://journals.lww.com/aidsonline/pages/articleviewer.aspx?year=2013&issue=11130&article=00006&type=abstract
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectHCV
dc.subjectHIV
dc.subjectPEGYLATED INTERFERON
dc.subjectRIBAVIRIN
dc.titleVariations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución